AllianceBernstein’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
VCM
OFM
LCM
DFO
AllianceBernstein's NUVB Position: Q1 2026 in Review
AllianceBernstein increased its Nuvation Bio (NUVB) stake by 3.7% in Q1 2026, buying an estimated $46.9K and bringing the position to 237,503 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1961.
AllianceBernstein first reported a position in NUVB in Q2 2021 and has held it in 20 quarters since. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.
- AllianceBernstein held 237,503 shares of Nuvation Bio worth $2.13M as of Q1 2026.
- AllianceBernstein bought 8,414 Nuvation Bio shares in Q1 2026, an estimated $46.9K.
- Nuvation Bio made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #1961 holding.
- AllianceBernstein first reported a position in Nuvation Bio in Q2 2021 and has held it in 20 quarters since.
- 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.